Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Advanced Micro Devices - Moderated (AMD) -- Ignore unavailable to you. Want to Upgrade?

To: bacchus_ii who wrote (43910)	6/11/2001 10:54:18 PM
From: Bill Jackson	Respond to of 275872

bacchus, Drugs are very highly regulated and there are huge barriers to entry that are analogous to the entry barrier to a competitor to windows. In fact there can never be a true competitor to windows as there are too many applications locked into the windows embrace. Sure we can have linux with a few thousand apps, all of which are a PITA to use with current GUIs. Compared to the 100,000 windows applications it is nothing, however a good iffice suite could be made and that is the threat that drives MSFT as we speak. Let a linux come along that could displace windows and you see all the msft patents dragged out of the cupboards if copyright faiuled to bar the way. Same for drug companies and they have a far shorter window of opportunity. 17 years of patent and it can take 5-7 years to get approval, so they get 10+ years of monopoly and then exact copies appear....no copyright here. yet they manage to get huge and they play all the games to keep prices high. Claritin is over the counter in Canada, prescription in the USA. Doctors and Pharmacist lobbys at work here and the company makes the same either way so it is a comples. Ant clotting drugs that cost $1 to make are sold at $700 per dose for acute heart attack patients, so the HMOs make the doctors use the $30 old method, 5% as effective, yet an approved treatment. Killed a old friend of mine, younger than me. Now the parallel differs a lot. MSFT has an infinite coptyight as they will make incrementals all the time, each a new copyright. Drug companies are under a far bigger gun. 10 years or so and then dead in the water, so they mucy come the earth for new stuff and test it. Seems to work, except when people die, as above. few dies with MSFT, unless you fel a world ruled by MSFT a fate worse than death. Bill

To: bacchus_ii who wrote (43910)	6/13/2001 10:36:16 PM
From: Joe NYC	Respond to of 275872

Gottfried, AMD has been 3 or 5 yeas profit less and, in the end, came with the athlon, while Intel making truck load of profit was keeping the Pentium with very little improvement. Profit ===> innovation !!! are you kidding... Let me understand this: AMD nearly wiped out all the shareholder equity, nearly went under in order to get Dresden on line and Athlon processor designed and accepted, and they did all this in order NOT to make profit? Your disagreement with Profit ==== > innovation may have merit, but it is really innovation ====> profit that is, innovation happens because of profit motive. If you remove the likelihood of profit (through some kind of government confiscation scheme) you remove incentive to innovate, which in turn will cripple innovation, growth in productivity, and growth in standards of living. Joe